Most frequently used drugs in suicide attempts and their organic complications in a tertiary care hospital
Main Article Content
Keywords
Suicide Attempt, Drug Overdose, Multiple Organ Failure, Mental Disorders, Retrospective Study
Abstract
Abstract
Background: A suicide attempt is an intentional act not resulting in death but carried out with the expectation of dying. Unlike completed suicide, suicide attempts are underreported. There is limited information regarding their clinical characteristics and organic complications.
Objective: To identify the most used drugs in suicide attempts and describe the associated organ complications in a third-level hospital.
Material and methods: Case series. A descriptive, observational, and retrospective study was conducted from 2019-2023. It included patients hospitalized due to intentional drug overdose derived from suicide attempt, and cases of accidental ingestion were excluded. Clinical and psychiatric variables, as well as organic complications were analyzed.
Results: A total of 35 patients were included: 74.3% women, 25.7% men, aged 18-77 years. Among them, 68.6% had major depressive disorder, 17.14% had anxiety disorder, and 11.42% had borderline personality disorder. The most frequently used drugs were benzodiazepines (28.57%), opioids, and antiepileptics (14.28%). The most frequent complications were neurological (40%), renal (25.7%), and respiratory (22.9%). Multiple organ dysfunction occurred in 31.4% of patients. Three patients died: 2 due to nosocomial infections and 1 directly related to drug overdose.
Conclusions: Benzodiazepines and opioids were the most frequently used drugs in suicide attempts. The main complications were neurological, renal, and respiratory, with a considerable risk of multiple organ dysfunction.
References
1. Organización Mundial de la Salud. Suicidio. Ginebra, Suiza: OMS; 2023. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/suicide
2. Borges G, Orozco R, Benjet C, et al. Comportamiento suicida en México: estado retrospectivo y actual. Salud Publica Mex. 2010;52:292-304.
3. Bertolote JM, Fleischmann A, De Leo D, et al. Suicide attempts, plans, and ideation in culturally diverse sites: the WHO SUPRE-MISS community survey. Psychol Med. 2005;35(10):1457-65. doi: 10.1017/S0033291705005404
4. Instituto Nacional de Estadística y Geografía. Estadísticas a propósito del Día Mundial para la Prevención del Suicidio. México: INEGI; 2022. Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2022/EAP_SUICIDIOS22.pdf
5. Instituto Nacional de Estadística y Geografía. Intentos de suicidio y suicidios. México: INEGI. Disponible en: https://www.inegi.org.mx/programas/suicidio/
6. Cai H, Xie XM, Zhang Q, et al. Prevalence of suicidality in major depressive disorder: a systematic review and meta-analysis of comparative studies. Front Psychiatry. 2021;12:690130. doi: 10.3389/fpsyt.2021.690130
7. Liu L, Pollock NJ, Contreras G, et al. Prevalence of suicidal ideation among adults in Canada: Results of the second Survey on COVID‑19 and mental health. Health Rep. 2022;33(5):3‑12. doi: 10.25318/82-003-x202200500002‑eng
8. Torres B. Aumentan suicidios en México. UNAM Global; 2022. Disponible en: https://unamglobal.unam.mx/global_revista/aumentan-suicidios-en-mexico/
9. Miller TR, Swedler DI, Lawrence BA, et al. Incidence and lethality of suicidal overdoses by drug class. JAMA Netw Open. 2020;3(3):e200607. doi: 10.1001/jamanetworkopen.2020.0607
10. Moranchel García L. Abordaje toxicológico del paciente con intento suicida. Med Int Mex. 2021;37(5):686-93.
11. Mégarbane B, Risède P, Clément B, et al. Acute poisoning-related admissions to adult emergency departments: patterns, management, and associated health care costs. Clin Toxicol (Phila). 2023;61(2):123-32. doi: 10.1080/15563650.2022.2157282
12. Schmid U, Ofner D, Schmid R, et al. Critical care management of acute intoxications, dynamics and changes over time: a cohort study. Intern Emerg Med. 2024;19(3):613-22. doi: 10.1007/s11739-024-03570-2
13. Marshall JC. Measuring organ dysfunction. Med Klin Intensivmed Notfmed. 2020;115(Suppl 1):15-20. doi: 10.1007/s00063-020-00660-9
14. Knaus WA, Draper EA, Wagner DP, et al. Prognosis in acute organ-system failure. Ann Surg. 1985;202(6):685-93. doi: 10.1097/00000658-198512000-00004
15. Marsh HM. Metabolic integrity of specific organ systems. Clin Chem. 1990;36(8 Pt 2):1547-51.
16. Levin A, Ahmed SB, Carrero JJ, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney Int. 2024;105(4):684-701. doi: 10.1016/j.kint.2023.10.016
17. Li M, Wang Y, Lv TT, et al. Mapping the incidence of drug-induced liver injury: a systematic review and meta-analysis. J Dig Dis. 2023;24(5):332-9. doi: 10.1111/1751-2980.13205
18. Asim M, Amin F, El-Menyar A. Multiple organ dysfunction syndrome: Contemporary insights on the clinicopathological spectrum. Qatar Med J. 2020;2020(1):22. doi: 10.5339/qmj.2020.22
19. Marshall JC. A Scoring System for Multiple Organ Dysfunction Syndrome. In: Reinhart K, Eyrich K, Sprung C, eds. Sepsis (Update in Intensive Care and Emergency Medicine, vol 18). Springer, Berlin, Heidelberg; 1994:38-49. doi: 10.1007/978‑3‑642‑85036‑3_4
20. Haug T, Rylander C, Reikvam Å, et al. Acute kidney injury in adult intensive care patients: incidence, time-course, risk factors, and mortality. Acta Anaesthesiol Scand. 2022;66(7):884-92. doi: 10.1111/aas.14000
21. Daly C, Griffin E, Corcoran P, et al. A national case fatality study of drugs taken in intentional overdose. Int J Drug Policy. 2020;76:102609. doi: 10.1016/j.drugpo.2019.102609
22. Choi NG, Choi BY, Marti CN, et al. Associations of medical outcome severities with substances involved in suicide attempt cases aged 50 and older reported to U.S. Poison Centers, 2016-2023. BMC Med. 2024;22(1):187. doi: 10.1186/s12916-024-03623-5
23. Scholl L, Seth P, Kariisa M, et al. Drug and opioid-involved overdose deaths—United States, 2013-2017. JAMA. 2019;322(16):1532-44. doi: 10.1001/jama.2019.12890
24. Shilpa D’Sa, Chacko B, Sudarsan T, et al. Nosocomial infection acquired during intensive care admission impacts mortality in patients admitted with deliberate self-harm. J Emerg Med Trauma Acute Care. 2020;2:12. doi: 10.5339/jemtac.2020.12
25. Geith S, Didden C, Rabe C, et al. Lessons to be learned: identifying high-risk medication and circumstances in patients at risk for suicidal self-poisoning. Int J Ment Health Syst. 2022;16(1):4. doi: 10.1186/s13033-021-00513-8
26. Borges G, Wilcox HC, Medina-Mora ME, et al. Prevalencia de vida y a 12 meses, factores psiquiátricos y uso de servicios. Salud Ment. 2005;28:40-7.
27. Bermúdez-Navas E, San Segundo-Rivera D, Álvarez JC, et al. Suicidio en pacientes con trastorno por uso de sustancias: serie de casos. Rev Asoc Esp Neuropsiq. 2024;44(146). doi: 10.4321/s0211-57352024000200004
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.